Page 54 - Read Online

Singh et al. Cancer Drug Resist. 2025;8:56 Page 19 of 20

108. Tan S, Gou Q, Pu W, et al. Circular RNA F-circEA produced from EML4-ALK fusion gene as a novel liquid biopsy biomarker for
non-small cell lung cancer. Cell Res. 2018;28:693-5. DOI PubMed PMC
109. Ge L, Sun Y, Shi Y, et al. Plasma circRNA microarray profiling identifies novel circRNA biomarkers for the diagnosis of ovarian
cancer. J Ovarian Res. 2022;15:58. DOI PubMed PMC
110. Borkar S, Markus F, Oetting A, et al. Detection of ESR1 mutations in tissue and liquid biopsy with novel next-generation sequencing
and digital droplet PCR assays: insights from multi-center real life data of almost 6000 patients. Cancers. 2025;17:1266. DOI PubMed
PMC
111. Kumar MA, Baba SK, Sadida HQ, et al. Extracellular vesicles as tools and targets in therapy for diseases. Signal Transduct Target Ther.
2024;9:27. DOI PubMed PMC
112. Hama Faraj GS, Hussen BM, Abdullah SR, et al. Advanced approaches of the use of circRNAs as a replacement for cancer therapy.
Noncoding RNA Res. 2024;9:811-30. DOI PubMed PMC
113. Tao X, Ke X, Xu G. *Mechanisms of circular RNA in drug resistance of lung cancer: therapeutic targets, biomarkers, and future research
directions. Discov Oncol. 2025;16:896. DOI PubMed PMC
114. Kirio K, Patop IL, Anduaga AM, et al. Circular RNAs exhibit exceptional stability in the aging brain and serve as reliable age and
experience indicators. Cell Rep. 2025;44:115485. DOI PubMed PMC
115. Rashedi S, Mardani M, Rafati A, et al. Circular RNAs as prognostic and diagnostic biomarkers in renal cell carcinoma. J Clin Lab Anal.
2022;36:e24670. DOI PubMed PMC
116. Fosse V, Oldoni E, Bietrix F, et al.; PERMIT group. Recommendations for robust and reproducible preclinical research in personalised
medicine. BMC Med. 2023;21:14. DOI PubMed PMC
117. Kuwamoto-Imanishi S, Fujii H. Functions and potential clinical applications of circular RNAs in hepatocellular carcinoma. Hepatoma
Res. 2025;11:15. DOI
118. Shi H, Zhou Y, Jia E, et al. Comparative analysis of circular RNA enrichment methods. RNA Biol. 2022;19:55-67. DOI PubMed PMC
119. Karagianni K, Bibi A, Madé A, et al.; EU-CardioRNA COST Action CA17129. Recommendations for detection, validation, and
evaluation of RNA editing events in cardiovascular and neurological/neurodegenerative diseases. Mol Ther Nucleic Acids.
2024;35:102085. DOI PubMed PMC
120. Liu H, Hao W, Yang J, Zhang Y, Wang X, Zhang C. Emerging roles and potential clinical applications of translatable circular RNAs in
cancer and other human diseases. Genes Dis. 2023;10:1994-2012. DOI PubMed PMC
121. Antoniou M, Kolamunnage-Dona R, Wason J, et al. Biomarker-guided trials: challenges in practice. Contemp Clin Trials Commun.
2019;16:100493. DOI PubMed PMC
122. Alqahtani S, Alqahtani T, Venkatesan K, et al. Unveiling pharmacogenomics insights into circular RNAs: toward precision medicine in
cancer therapy. Biomolecules. 2025;15:535. DOI PubMed PMC
123. Malviya A, Bhuyan R. The recent advancements in circRNA research: from biogenesis to therapeutic interventions. Pathol Res Pract.
2023;248:154697. DOI PubMed
124. Betz M, Massard V, Gilson P, et al. ESR1 gene mutations and liquid biopsy in ER-positive breast cancers: a small step forward, a giant
leap for personalization of endocrine therapy? Cancers. 2023;15:5169. DOI PubMed PMC
125. Li Q, Geng S, Luo H, et al. Signaling pathways involved in colorectal cancer: pathogenesis and targeted therapy. Signal Transduct
Target Ther. 2024;9:266. DOI PubMed PMC
126. Cui YB, Wang LJ, Xu JH, et al. Recent progress of circRNAs in hematological malignancies. Int J Med Sci. 2024;21:2544-61. DOI
PubMed PMC
127. Li W, Liu JQ, Chen M, Xu J, Zhu D. Circular RNA in cancer development and immune regulation. J Cell Mol Med. 2022;26:1785-98.
DOI PubMed PMC
128. de Gonzalo-Calvo D, Karaduzovic-Hadziabdic K, Dalgaard LT, et al. Machine learning for catalysing the integration of noncoding RNA
in research and clinical practice. EBioMedicine. 2024;106:105247. DOI PubMed PMC
129. Pedraz-Valdunciel C, Rosell R. Defining the landscape of circRNAs in non-small cell lung cancer and their potential as liquid biopsy
biomarkers: a complete review including current methods. Extracell Vesicles Circ Nucl Acids. 2021;2:179-201. DOI PubMed PMC
130. Shi Y, Song R, Wang Z, et al. Potential clinical value of circular RNAs as peripheral biomarkers for the diagnosis and treatment of major
depressive disorder. EBioMedicine. 2021;66:103337. DOI PubMed PMC

47